Tuesday, August 19, 2014

Amgen parathyroid drug for dialysis patients reaches endpoints in 2nd phase 3 study | Nephrology News & Issues

Amgen parathyroid drug for dialysis patients reaches endpoints in 2nd phase 3 study | Nephrology News & Issues

No comments:

Post a Comment